JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
There are no items in your shopping cart
Featured Products
Axon 3956
CAS [2138861-99-9]
MF C28H30FN3O4MW 491.55
ABBV-744 is an orally available first-in-class highly BDII (Bromodomain II)-selective (>100 X selectivity over BDI) BET bromodomain inhibitor, currently is being investigated to treat AML and metastic castration-resistant prostate cancer.
KEYWORDS: ABBV-744 | BDII selective BET bromodomain inhibitor | ABBV744 | ABBV 744 | CT-ABBV744 | CAS [2138861-99-9] | Histone | BET (BRD) | Inhibitor | Proteins | BDII
N-Ethyl-4-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridine-2-carboxamide
[2138861-99-9]
Potent and selective BET bromodomain inhibitor
The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.
Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!
* Required Fields